DMS Group Records Solid Growth in Q1 2025

Diagnostic Medical Systems (DMS) Group reported a robust start to 2025, achieving a 10% increase in turnover for the first quarter, totaling €10.9 million compared to the same period in 2024. The growth is attributed to the strength in Radiology revenues, which rose by 18%, although Bone Densitometry experienced a 12% slowdown.

Geographically, significant progress was noted in the Americas, where revenue surged by 138.1% to €2.3 million, aided by key partnerships with Carestream Health and Fujifilm Healthcare. Growth in Asia was also notable, with revenues jumping 98% to €0.7 million. European operations remained relatively steady, seeing a 3% increment resulting in €6.5 million.

Looking ahead, DMS Group anticipates further growth, propelled by a strategic contract with Ukraine for emergency radiology units and the upcoming launch of the innovative Onyx mobile radiology unit, alongside strategic US partnerships.